Pharmafile Logo
Pharmafocus logo
Advanced Search
lauritzen1_k100

Securing the cold chain with new solutions

October 23, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cold chain, manufacturing, supply chain

Ben Hargreaves examines the emerging practical and technological solutions that are aiming to improve patients’ access to medicines in a …

Feature
save_our_nhs

Pharma companies accused of charging NHS twice for treatments

October 23, 2017
Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical

A new report published by STOP AIDS and Global Justice Now takes aim at three pharmaceutical companies who have taken …

News
antibiotics

Public Health England sounds warning against overuse of antibiotics

October 23, 2017
Medical Communications, Sales and Marketing Antibiotics, biotech, drugs, pharma, pharmaceutical

Public Health England (PHE) has unveiled the findings from its English surveillance programme for antimicrobial utilisation and resistance report, suggesting …

News

GSK’s shingles vaccine scores US approval

October 23, 2017
Sales and Marketing FDA, GSK, Shingrix, pharma, shingles

GlaxoSmithKline has announced that its shingles vaccine Shingrix (Zoster Vaccine Recombinant, Adjuvanted) has been awarded FDA approval for the prevention …

News

MSD cuts 1,800 jobs in US operations restructure

October 23, 2017
Manufacturing and Production, Sales and Marketing MSD, Merck, job cuts, pharma

MSD has revealed its intention to cut 1,800 sales positions from its workforce in the US. Across the total number, …

News
baby_powder

$417 million case against J&J thrown out

October 23, 2017
Sales and Marketing Johnson & Johnson, biotech, drugs, pharma, pharmaceutical, talc

A judge in California has thrown out the lawsuit made by a woman who had alleged that Johnson & Johnson’s …

News
pollution_smoke

Report reveals impact of pollution, with 9m deaths worldwide

October 20, 2017
Medical Communications biotech, drugs, pharma, pharmaceutical, pollution

A new report published in The Lancet has revealed that all forms of pollution are linked with 9 million deaths …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

October 20, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

Another week gone, and it’s deadline day here at Pharmafocus, meaning you can look forward to our November issue next …

News
dna-1903319_960_720

Small number of mutations driving most cancers

October 20, 2017
Medical Communications, Research and Development Cancer, biotech, drugs, pharma, pharmaceutical

Research from scientists at the Wellcome Trust Sanger Institute has found that only between one and 10 genetic mutations are …

News
teva_copy

Teva under investigation over illegal rebate offers to Ontario pharmacies

October 20, 2017
Medical Communications, Sales and Marketing Teva, fentanyl, opioids, oxycodone

Israeli drugmaker Teva has again become embroiled in a scandal investigated by the Ontario government for allegedly bribing pharmacies to …

News
celgene_building

Celgene drops $710m drug, shares nosedive 7%

October 20, 2017
Medical Communications, Research and Development Celgene, biotech, drugs, pharma, pharmaceutical

Celgene took a gamble when it spent $710 million up-front on an inflammatory disorder treatment, but it now looks likely …

News
donor_card

Worrying number of organ donations blocked by families

October 19, 2017
Medical Communications biotech, drugs, organ donation, pharma, pharmaceutical

A report from the BBC has found that 505 registered organ donors had their decision blocked by relatives, over the …

News
portraits-1474_approved_cut

Access to Innovation: Beyond a ‘pharma-only’ approach

October 19, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, ecco, oncology

Peter Naredi, of ECCO, explores how a multi-dimensional approach is necessary to ensure that patients receive access to the most …

Feature
lilly_entrance_web

Lilly teams up with CureVac in $1.8 billion cancer vaccine partnership

October 19, 2017
Research and Development, Sales and Marketing Cancer, CureVac, Eli Lilly, Vaccine

Eli Lilly has announced it is to partner up with CureVac to leverage its proprietary RNActive technology in order to …

News
georgescangos

Vir Biotech blasts out of the blocks, with $500m in bank

October 19, 2017
Medical Communications, Sales and Marketing Vir Biotechnology, biotech, drugs, pharma, pharmaceutical

All has been quiet since former Biogen CEO, George Scangos, departed the company and then set up Vir Biotechnology in …

News

Novo’s diabetes treatment semaglutide gets unanimous FDA backing

October 19, 2017
Sales and Marketing Novo Nordisk, diabetes, semaglutide

Novo Nordisk is celebrating the news that its diabetes drug semaglutide has won the favour of FDA experts, with one …

News
gilead-sciences

Gilead gets FDA nod for revolutionary blood cancer treatment

October 19, 2017
Sales and Marketing CAR-T, Gilead, Yescarta, biotech, drugs, pharma, pharmaceutical

Only weeks after Gilead announced the completion of Kite, it got the news it was hoping for with the FDA’s …

News
shutterstock_212432119

First-ever study in the personalised treatment of rare cancers brings promising results

October 18, 2017
Research and Development Cancer, Cancer Research UK, personalised medicine, pharma, rare cancer

The first-ever trial to treat patients for rare cancers in a personalised manner based on the characteristics of their individual …

News
mit-ai-cancer-detection-01_0

Breakthrough AI able to identify 97% of breast cancer risk

October 18, 2017
Research and Development MIT, biotech, breast cancer, drugs, pharma, pharmaceutical

 Scientists at MIT’s Computer Science and Artificial Intelligence Laboratory have developed a machine learning AI system that is able diagnose …

News

Novartis sheds generics plant and 450 jobs amid pricing pressure

October 18, 2017
Manufacturing and Production, Research and Development Novartis, US, closure, generics, manufacturing, pharma

Novartis has announced its intention to shut down its US generics manufacturing plant in Broomfield, Colorado, a move that will …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026